BRIEF-Cempra reports anti-nash effects of Solithromycin interim results from phase 2 study
September 29, 2016 at 16:19 PM EDT
* Nash effects of solithromycin: interim results from phase 2 study
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.